ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAA4.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $31,000 | +6.9% | 30,888 | +6.7% | 0.00% | – |
| Q4 2018 | $29,000 | -3.3% | 28,958 | -2.0% | 0.00% | – |
| Q3 2018 | $30,000 | -11.8% | 29,540 | -12.7% | 0.00% | – |
| Q2 2018 | $34,000 | -54.7% | 33,824 | -57.1% | 0.00% | – |
| Q1 2018 | $75,000 | -51.6% | 78,811 | -54.6% | 0.00% | – |
| Q4 2017 | $155,000 | +384.4% | 173,641 | +449.7% | 0.00% | – |
| Q3 2017 | $32,000 | +6.7% | 31,588 | +5.2% | 0.00% | – |
| Q2 2017 | $30,000 | 0.0% | 30,035 | +1.0% | 0.00% | – |
| Q1 2017 | $30,000 | – | 29,750 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYMPHONY ASSET MANAGEMENT LLC | 23,872,000 | $18,748,000 | 4.04% |
| PFM Health Sciences, LP | 49,764,825 | $39,319,000 | 1.16% |
| Partner Investment Management, L.P. | 659,175 | $521,000 | 0.89% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 40,000,000 | $31,402,000,000 | 0.87% |
| Bruce & Co., Inc. | 6,000,000 | $4,200,000 | 0.87% |
| CANYON CAPITAL ADVISORS LLC | 36,500,000 | $28,747,000 | 0.62% |
| PenderFund Capital Management Ltd. | 2,000,000 | $1,571,000 | 0.53% |
| Shaolin Capital Management LLC | 4,000,000 | $3,136,000 | 0.48% |
| Castle Creek Arbitrage, LLC | 2,310,000 | $1,815,000 | 0.46% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 5,500,000 | $4,368,000 | 0.27% |